SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd (SMSPHARMA) last traded at ₹356, a market capitalisation of ₹3,336 crore, on a P/E of 32.5. Over the past 52 weeks the stock has ranged between ₹221 and ₹448. SMS Pharmaceuticals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹207 crore and net profit of ₹21 crore. The next scheduled event is a record date on 16 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
SMS Pharmaceuticals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
SMS Pharmaceuticals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹207 cr, up 5.6% from ₹196 cr a year earlier. Net profit was ₹21 cr, up 5.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 197 | 173 | 248 | 196 | 242 | 210 | 238 | 207 |
| Expenses | 165 | 140 | 207 | 157 | 194 | 167 | 198 | 166 |
| Operating profit | 31 | 33 | 41 | 39 | 48 | 44 | 40 | 41 |
| OPM % | 16% | 19% | 16% | 20% | 20% | 21% | 17% | 20% |
| Other income | 1 | 2 | 1 | 1 | 1 | 4 | 3 | 2 |
| Interest | 5 | 4 | 5 | 6 | 6 | 6 | 5 | 6 |
| Depreciation | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 |
| Profit before tax | 20 | 22 | 29 | 24 | 34 | 31 | 27 | 27 |
| Tax % | 29% | 24% | 30% | 23% | 26% | 26% | 23% | 26% |
| Net profit | 14 | 18 | 20 | 20 | 25 | 23 | 33 | 21 |
| EPS (₹) | 1.66 | 2.15 | 2.29 | 2.31 | 2.70 | 2.51 | 3.49 | 2.23 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
SMS Pharmaceuticals Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 563 | 520 | 522 | 709 | 783 | 887 | 898 |
| Operating profit | 121 | 115 | 55 | 117 | 139 | 171 | 173 |
| OPM % | 22% | 22% | 10% | 16% | 18% | 19% | 19% |
| Net profit | 63 | 62 | -7 | 50 | 69 | 102 | 102 |
| EPS (₹) | 7.38 | 7.35 | -0.83 | 5.88 | 7.80 | 10.89 | 10.93 |
TTM is the trailing twelve months to the most recent quarter.
SMS Pharmaceuticals Ltd growth and returns
- 10 Years
- 4%
- 5 Years
- 10%
- 3 Years
- 19%
- TTM
- 10%
- 10 Years
- 10%
- 5 Years
- 10%
- 3 Years
- 155%
- TTM
- 40%
- 10 Years
- 16%
- 5 Years
- 16%
- 3 Years
- 39%
- 1 Year
- 51%
- 10 Years
- 11%
- 5 Years
- 10%
- 3 Years
- 12%
- Last Year
- 14%
SMS Pharmaceuticals Ltd shareholding pattern
Promoters held 68.07% at Jun 2026, up from 66.27% at Jun 2025. FIIs 0.65% and DIIs 2.83%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 64.67% | 64.67% | 66.27% | 66.27% | 68.07% | 68.07% | 68.07% | 68.07% |
| FIIs | 0.52% | 0.31% | 0.08% | 0.03% | 0.28% | 0.04% | 0.31% | 0.65% |
| DIIs | 2.55% | 2.55% | 2.43% | 3.03% | 2.88% | 3.21% | 3.02% | 2.83% |
| Public | 32.27% | 32.47% | 31.23% | 30.68% | 28.77% | 28.69% | 28.60% | 28.45% |
| No. of shareholders | 33,136 | 34,973 | 35,332 | 33,652 | 34,157 | 34,378 | 32,397 | 31,489 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming SMS Pharmaceuticals Ltd events
The next scheduled event is a record date on 16 Sept 2026.
- Record dateRecord date for final dividend payment
- AGM38th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
SMS Pharmaceuticals Ltd corporate filings
- Copy of newspaper publication regarding the 38th Annual General Meeting to be held through VC/ other Audio Visual MeansCompany Updatelow impact
Cruxal's analysis: SMS Pharmaceuticals Ltd has published a newspaper notice regarding its 38th Annual…
Read the full analysis - Please find the enclosureCompany Updatelow impact
Cruxal's analysis: SMS Pharmaceuticals Limited has issued a routine communication to shareholders regarding…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track SMS Pharmaceuticals Ltd
Cruxal reads every SMS Pharmaceuticals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.